QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
165 hedge funds and large institutions have $2.5B invested in QIAGEN NV in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 53 increasing their positions, 55 reducing their positions, and 16 closing their positions.
256% more call options, than puts
Call options by funds: $1.01M | Put options by funds: $284K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 16
18% more capital invested
Capital invested by funds: $2.12B → $2.5B (+$381M)
10% more funds holding
Funds holding: 150 → 165 (+15)
4% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$45.9M |
| 2 |
Primecap Management
Pasadena,
California
|
+$35.8M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$35M |
| 4 |
Barclays
London,
United Kingdom
|
+$17.2M |
| 5 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$16.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
-$39.4M |
| 2 |
HJGA
Hardman Johnston Global Advisors
Stamford,
Connecticut
|
-$30.7M |
| 3 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$13.8M |
| 4 |
GI
GLG Inc
New York
|
-$7.72M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$7.3M |
QGENF Hedge Fund Activity: Q4 2013 in Review
165 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q4 2013, worth a combined $2.5B — up 18% from $2.12B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new QGENF positions and 16 closed out — a net gain of 16 holders — while 53 added to existing stakes and 55 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $45.9M. The largest seller was Credit Agricole, cutting an estimated $39.4M.
- 165 institutional investors held QIAGEN NV (QGENF) as of Q4 2013, up from 150 in Q3 2013.
- Funds reported $2.5B of QIAGEN NV stock for Q4 2013, up 18% quarter-over-quarter.
- 32 funds opened new QIAGEN NV positions in Q4 2013 and 16 closed out, a net change of +16 holders.
- The largest QIAGEN NV buyer in Q4 2013 was OrbiMed, an estimated $45.9M added.
- The largest QIAGEN NV seller in Q4 2013 was Credit Agricole, an estimated $39.4M sold.
Based on aggregated 13F filings for Q4 2013.